Table 2.
Comparison of antibacterial activities (zone of inhibitions) of BAPs from P. ostreatus cultivated and P. ostreatus wild with tested antibiotics.
| Microorganism | BAPs from PoC | BAPs from PoW | Amoxycillin | Ampicillin | Methicillin | Azithromycin | Erythromycin | Clindamycin | Nystatin | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5 μg | 15 μg | 30 μg | 5 μg | 15 μg | 30 μg | 30 μg | 10 μg | 5 μg | 30 μg | 15 μg | 10 μg | 50 μg | |
| S. mutans | 7.1 ± 1.0 | 15.33 ± 1.5 | 20.5 ± 0.5 | 0 | 6.83 ± 0.20 | 11.56 ± 0.45 | 21.16 ± 0.15 | 16.26 ± 0.25 | 0 | 26.2 ± 0.2 | 21 ± 0 | 30.23 ± 0.25 | # |
| S. oralis | 7.96 ± 0.55 | 17 ± 2.6 | 19 ± 1.0 | 0 | 7.53 ± 0.50 | 11.06 ± 0.20 | 13.13 ± 0.11 | 8.16 ± 0.15 | 0 | 23.2 ± 0.2 | 23.2 ± 0.2 | 26.2 ± 0.17 | # |
| L. acidophilus | 11.76 ± 0.68 | 20.16 ± 0.76 | 27 ± 1.0 | 7.73 ± 0.37 | 10.43 ± 0.51 | 16 ± 1.0 | 30.16 ± 0.20 | 30.23 ± 0.25 | 0 | 24.13 ± 0.15 | 26.3 ± 0.26 | 29.2 ± 0.17 | # |
| A. viscosus | 7.33 ± 0.57 | 17.36 ± 0.55 | 19.53 ± 0.50 | 7 ± 1.0 | 9.86 ± 0.80 | 12.76 ± 0.68 | 11.23 ± 0.25 | 10.2 ± 0.2 | 0 | 21.23 ± 0.20 | 23.36 ± 0.35 | 26.23 ± 0.20 | # |
| S. aureus | 14.2 ± 0.72 | 15.53 ± 0.50 | 18.6 ± 0.52 | 4.2 ± 0.72 | 6.2 ± 0.72 | 10.5 ± 0.5 | 28.23 ± 0.20 | 32.4 ± 0.4 | 0 | 26.23 ± 0.20 | 29.16 ± 0.15 | 32.16 ± 0.20 | # |
| E. coli | 0 | 17.6 ± 0.52 | 21.76 ± 0.68 | 0 | 4.53 ± 0.50 | 11.43 ± 0.51 | 20.26 ± 0.25 | 15.3 ± 0.3 | 0 | 22.16 ± 0.20 | 18.13 ± 0.15 | 0 | # |
| E. faecalis | 13.3 ± 0.7 | 16.9 ± 0.1 | 19.83 ± 0.20 | 20.66 ± 0.41 | 22.3 ± 0.60 | 24.36 ± 0.32 | 32.33 ± 0.30 | 32.1 ± 0.1 | 0 | 26.03 ± 0.05 | 29.1 ± 0.17 | 10.33 ± 0.41 | # |
| C. albicans | 4.86 ± 0.23 | 15.33 ± 0.57 | 17.66 ± 1.52 | 5.83 ± 0.72 | 7.36 ± 0.32 | 11.6 ± 0.52 | * | * | * | * | * | * | 0 |
*Antimicrobial activity was not performed as the target pathogen was a fungus. #Antibacterial activity was not performed because Nystatin is an antifungal agent.